Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|November 25, 2003
Adult T-biphenotypic acute leukaemia: clinical and biological features and outcomeM T Rubio, N Dhedin, C Boucheix, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Blood|January 1, 1980
Acute monoblastic leukemia: a clinical and biologic study of 74 casesG Tobelem, C Jacquillat, C Chastang, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous stem cell transplantation in chronic myeloid leukemia: a single center experienceA Pigneux, C Faberes, J M Boiron, et al.
Bone Marrow Transplantation|May 1, 1996
High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemiaF X Mahon, C Fabères, M Montastruc, et al.
Blood|December 3, 1998
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alphaF X Mahon, C Fabères, S Pueyo, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Bone Marrow Transplantation|November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experienceR M Lowenthal, C Fabères, G Marit, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.
Pageof 27